HomeOpen Access NewsDiseases & Conditions

Diseases & Conditions

Common pesticides and chemicals damage “good” gut bacteria

A significant study from the University of Cambridge finds that everyday pesticides and industrial chemicals can kill beneficial gut bacteria, potentially harming digestion, immunity, and overall health.

World Psoriasis Day: Advancing early detection of psoriatic arthritis through iPROLEPSIS

Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with psoriasis and psoriatic arthritis (PsA).

Scientists reveal the exact moment your brain switches off to sleep

Breakthrough research shows the brain doesn't drift into sleep gradually; it hits a sudden "tipping point." Discover how scientists pinpoint the second your brain shuts down each night.

UK’s first MS patient receives CAR T-cell therapy in landmark trial

A UK patient has become the first with multiple sclerosis (MS) to receive cutting-edge CAR T-cell therapy, as scientists test whether the one-time treatment can halt disease progression.

Canada’s youth facing growing opioid crisis: Calls for urgent action

Explore the rising youth involvement in the Canada opioid crisis and the urgent need for effective interventions and support.

From ‘analogue to digital’: Will digital transformation improve HIV care?

Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move from ‘analogue to digital’.

MS may start years before symptoms, UCSF study reveals

UCSF researchers found early immune signs of multiple sclerosis years before symptoms, a discovery that could transform diagnosis and care.

Largest-ever £26 million trial launches across UK to slow Parkinson’s disease

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt disease progression.

Seven AI tools selected for MHRA’s AI Airlock programme to detect diseases early

Seven AI technologies have been chosen for the next phase of the MHRA’s AI Airlock programme, aiming to improve early detection of diseases.

Faster MRI scans could make early dementia diagnosis more accessible

Researchers at UCL have developed a method to reduce MRI scan times for dementia diagnosis by two-thirds, potentially doubling daily scan capacity and improving access to early care.

New gene therapy could prevent kidney damage in people with type 1 diabetes

University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes.

Nanomedicine breakthrough: Nanoparticles reverse Alzheimer’s pathology in mice

A UCL-led study shows bioactive nanoparticles can restore blood-brain barrier function and clear amyloid-β in mice, reversing Alzheimer's-like brain changes.

NHS to screen newborns for life-threatening metabolic disorder HT1

A new NHS screening programme will test babies for hereditary tyrosinemia type 1 at five days old, enabling early treatment to prevent organ damage, liver failure, and other serious complications.

COVID-19 could cost UK £7 billion a year without autumn vaccinations

A new OHE model shows that stopping annual autumn COVID-19 vaccinations could cost the UK economy £7 billion each year.

Clean air could prevent thousands of late-life eczema cases, UK Biobank study finds

A UK Biobank study of over 300,000 participants reveals that reducing air pollution could prevent nearly 16% of late-onset eczema cases.

New study reveals how microplastics may affect human health

A new study shows microplastics can alter gut bacteria, mimicking changes linked to depression and colorectal cancer.

First-of-its-kind study investigates vaping’s impact on lung health

The University of Birmingham leads £1.55m research to assess the long-term effects of vaping on respiratory cells, immunity, and lung microbiome in smokers.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders